M28 Capital Management LP Arrowhead Pharmaceuticals, Inc. Transaction History
M28 Capital Management LP
- $123 Million
- Q4 2024
A detailed history of M28 Capital Management LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, M28 Capital Management LP holds 67,400 shares of ARWR stock, worth $831,716. This represents 1.03% of its overall portfolio holdings.
Number of Shares
67,400
Previous 67,400
-0.0%
Holding current value
$831,716
Previous $1.3 Million
2.84%
% of portfolio
1.03%
Previous 1.24%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
303Shares Held
95.7MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$194 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$150 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$137 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$74.2 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$64.6 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.31B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...